Safety and Efficacy Therapy of Gemcitabine and Erbitux® to R0 or R1 Resected Pancreatic Cancer

NCT00395252 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

76

Enrollment

OTHER

Sponsor class

Conditions

Adenocarcinoma

Interventions

DRUG: Cetuximab (Erbitux®) and Gemcitabine

Sponsor

Carmen Schade-Brittinger